The independent source for health policy research, polling, and news.
KFF’s policy research provides facts and analysis on a wide range of policy issues and public programs.
KFF designs, conducts and analyzes original public opinion and survey research on Americans’ attitudes, knowledge, and experiences with the health care system to help amplify the public’s voice in major national debates.
KFF Health News is a national newsroom that produces in-depth journalism about health issues and is one of the organization’s core operating programs.
Antiviral medications, including those that treat hepatitis C and HIV/AIDS, cost the Medicaid program more money (before rebates) than any other group of outpatient prescription drugs for each year from 2014 to 2017, according to a new KFF analysis.
This primer provides basic information about global health and U.S. government programs that address global health. The first several sections provide an overview of the field of global health and describe current global health issues. The subsequent sections describe U.S. government support for global health, from the programs the government supports, to the organization of the U.S. response, the budgets and financing of U.S. global health programs, and the U.S. government’s relationship with multilateral institutions and international partners.
This data note examines the public’s knowledge and concerns about antibiotic resistance and also gauges the public’s experiences using antibiotics and their interactions with doctor and health care providers.
This annual survey of employers provides a detailed look at trends in employer-sponsored health coverage, including premiums, employee contributions, cost-sharing provisions, offer rates, wellness programs, and employer practices. Annual premiums for employer-sponsored family health coverage reached $21,342 this year, up 4% from last year, with workers on average paying $5,588 toward the cost of their coverage.
This report summarizes results from a Medicaid pharmacy benefit survey of all 50 states and the District of Columbia (DC) conducted by Kaiser Family Foundation and Health Management Associates in 2019.
This Issue Brief describes what has changed in the broader international Ebola response landscape since 2014, and considers the status of USG engagement in responses to the Ebola outbreaks in DRC. Updated, August 2018.
The Global HIV/AIDS Timeline is an ongoing reference tool for the many political, scientific, cultural, and community developments that have occurred over the history of the HIV/AIDS epidemic.
Ebola virus has a unique set of characteristics that determine how and why its spreads, and how deadly it can be. To better understand Ebola, this infographic compares it to twelve other infectious diseases that continue to represent public health challenges today and asks and answers five key questions about the disease.
The Senate Committee on Appropriations approved the FY19 State & Foreign Operations (SFOPs) appropriations bill (and accompanying report) on June 21, 2018. The SFOPs bill includes funding for U.S. global health programs at the State Department and the U.S. Agency for International Development (USAID).
The United States played a leading role in the international response to the 2014 Ebola outbreak in West Africa, providing the most financial support, mobilizing U.S. staff across the federal government, and jumpstarting international efforts to strengthen global health security.
© 2026 KFF